Velan Capital Investment Management LP

Investment Portfolio & 13F Holdings Analysis

About

Type: FundHoldings: 47Value: $90.0MLatest: 2025Q1

Velan Capital Investment Management LP is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 47 holdings worth $0.1 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

AI_NATIVE detailed information: This accession holds the following tickers:[
  "TIL",
  "SWTX",
  "SLRN",
  "CATX",
  "TERN",
  "TRML",
  "LQDA",
  "LRMR",
  "MLYS",
  "REPL",
  "ALEC",
  "AVTX",
  "GERN",
  "JSPR",
  "NXTC",
  "OVID",
  "PRQR",
  "PMVP",
  "TELA",
  "STRO",
  "EDSA",
  null,
  "TARA",
  "RZLT",
  "ACRS",
  "HRTX",
  "UPB",
  "PRAX",
  "FDMT",
  "TENX",
  "RGLS",
  "SCPH",
  "GOSS",
  "WVE",
  "CNTX",
  "ELDN",
  "ELEV",
  "ERAS",
  "IMNM",
  "DSGN",
  null,
  "KRON",
  "VRNA",
  "VTYX",
  null,
  "CRBP",
  "CTMX"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 47
Total Value: 90023167
Accession Number: 0000938552-25-000003
Form Type: 13F-HR
CIK: velan-capital-investment-management-lp
Manager Name: Velan-Capital-Investment-Management-Lp

Data Enrichment

94% identified

44 identified3 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

47 positions • $90.0M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 1 of 3

Sort by:

HERON THERAPEUTICS, INC. /DE/

HRTX|427746102

Shares:7.0M

Value:$15.4M

% of Portfolio:17.1% ($15.4M/$90.0M)

ACELYRIN, Inc.

SLRN|00445A100

Shares:3.4M

Value:$8.3M

% of Portfolio:9.2% ($8.3M/$90.0M)

SpringWorks Therapeutics, Inc.

SWTX|85205L107

Shares:185.5K

Value:$8.2M

% of Portfolio:9.1% ($8.2M/$90.0M)

Protara Therapeutics, Inc.

TARA|74365U107

Shares:1.7M

Value:$7.1M

% of Portfolio:7.9% ($7.1M/$90.0M)

Praxis Precision Medicines, Inc.

PRAX|74006W207

Shares:185.0K

Value:$7.0M

% of Portfolio:7.8% ($7.0M/$90.0M)

Verona Pharma plc

VRNA|925050106

Shares:95.0K

Value:$6.0M

% of Portfolio:6.7% ($6.0M/$90.0M)

488445206

Shares:665.0K

Value:$5.0M

% of Portfolio:5.5% ($5.0M/$90.0M)

Tourmaline Bio, Inc.

TRML|89157D105

Shares:319.1K

Value:$4.9M

% of Portfolio:5.4% ($4.9M/$90.0M)

Liquidia Corp

LQDA|53635D202

Shares:300.0K

Value:$4.4M

% of Portfolio:4.9% ($4.4M/$90.0M)

45779A846

Shares:904.0K

Value:$2.4M

% of Portfolio:2.7% ($2.4M/$90.0M)

scPharmaceuticals Inc.

SCPH|810648105

Shares:917.7K

Value:$2.4M

% of Portfolio:2.7% ($2.4M/$90.0M)

Mineralys Therapeutics, Inc.

MLYS|603170101

Shares:150.6K

Value:$2.4M

% of Portfolio:2.7% ($2.4M/$90.0M)

Replimune Group, Inc.

REPL|76029N106

Shares:182.1K

Value:$1.8M

% of Portfolio:2.0% ($1.8M/$90.0M)

Edesa Biotech, Inc.

EDSA|27966L306

Shares:687.5K

Value:$1.7M

% of Portfolio:1.9% ($1.7M/$90.0M)

Instil Bio, Inc.

TIL|45783C200

Shares:69.0K

Value:$1.2M

% of Portfolio:1.3% ($1.2M/$90.0M)

Rezolute, Inc.

RZLT|76200L309

Shares:400.0K

Value:$1.2M

% of Portfolio:1.3% ($1.2M/$90.0M)

Eledon Pharmaceuticals, Inc.

ELDN|28617K101

Shares:324.0K

Value:$1.1M

% of Portfolio:1.2% ($1.1M/$90.0M)

Perspective Therapeutics, Inc.

CATX|46489V302

Shares:500.0K

Value:$1.1M

% of Portfolio:1.2% ($1.1M/$90.0M)

Jasper Therapeutics, Inc.

JSPR|471871202

Shares:245.3K

Value:$1.1M

% of Portfolio:1.2% ($1.1M/$90.0M)

GERON CORP

GERN|374163103

Shares:655.0K

Value:$1.0M

% of Portfolio:1.2% ($1.0M/$90.0M)

Instrument	Shares		Other Manager	Value	% of Portfolio
HERON THERAPEUTICS, INC. /DE/(HRTXcusip427746102)	7.0M	QoQ 0.00% (+0) YoY 0.00% (-0)	All Managers (Combined)	$15.4M	17.1% ($15.4M/$90.0M)	QoQ +43.79% (+$4.7M) YoY -20.57% (-$4.0M)
ACELYRIN, Inc.(SLRNcusip00445A100)	3.4M	QoQ NEW(+3.4M) YoY NEW(+3.4M)	All Managers (Combined)	$8.3M	9.2% ($8.3M/$90.0M)	QoQ NEW(+$8.3M) YoY NEW(+$8.3M)
SpringWorks Therapeutics, Inc.(SWTXcusip85205L107)	185.5K	QoQ 0.00% (+0) YoY NEW(+185.5K)	All Managers (Combined)	$8.2M	9.1% ($8.2M/$90.0M)	QoQ +22.14% (+$1.5M) YoY NEW(+$8.2M)
Protara Therapeutics, Inc.(TARAcusip74365U107)	1.7M	QoQ +5.62% (-88.8K) YoY NEW(+1.7M)	All Managers (Combined)	$7.1M	7.9% ($7.1M/$90.0M)	QoQ -14.78% (-$1.2M) YoY NEW(+$7.1M)
Praxis Precision Medicines, Inc.(PRAXcusip74006W207)	185.0K	QoQ -38.33% (-115.0K) YoY -47.24% (-165.7K)	All Managers (Combined)	$7.0M	7.8% ($7.0M/$90.0M)	QoQ -69.65% (-$16.1M) YoY -67.25% (-$14.4M)
Verona Pharma plc(VRNAcusip925050106)	95.0K	QoQ +90.00% (+45.0K) YoY NEW(+95.0K)	All Managers (Combined)	$6.0M	6.7% ($6.0M/$90.0M)	QoQ +159.75% (+$3.7M) YoY NEW(+$6.0M)
(cusip488445206)✕	665.0K	QoQ +121.66% (+365.0K) YoY NEW(+665.0K)	All Managers (Combined)	$5.0M	5.5% ($5.0M/$90.0M)	QoQ +99.07% (+$2.5M) YoY NEW(+$5.0M)
Tourmaline Bio, Inc.(TRMLcusip89157D105)	319.1K	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$4.9M	5.4% ($4.9M/$90.0M)	QoQ -24.99% (-$1.6M) YoY -33.58% (-$2.5M)
Liquidia Corp(LQDAcusip53635D202)	300.0K	QoQ 0.00% (+0) YoY NEW(+300.0K)	All Managers (Combined)	$4.4M	4.9% ($4.4M/$90.0M)	QoQ +25.42% (+$897.0K) YoY NEW(+$4.4M)
(cusip45779A846)✕	904.0K	QoQ 0.00% (+0) YoY 0.00% (+0)	All Managers (Combined)	$2.4M	2.7% ($2.4M/$90.0M)	QoQ +2.28% (+$54.2K) YoY +13.49% (+$289.2K)
scPharmaceuticals Inc.(SCPHcusip810648105)	917.7K	QoQ NEW(+917.7K) YoY NEW(+917.7K)	All Managers (Combined)	$2.4M	2.7% ($2.4M/$90.0M)	QoQ NEW(+$2.4M) YoY NEW(+$2.4M)
Mineralys Therapeutics, Inc.(MLYScusip603170101)	150.6K	QoQ NEW(+150.6K) YoY NEW(+150.6K)	All Managers (Combined)	$2.4M	2.7% ($2.4M/$90.0M)	QoQ NEW(+$2.4M) YoY NEW(+$2.4M)
Replimune Group, Inc.(REPLcusip76029N106)	182.1K	QoQ +0.39% (-716) YoY NEW(+182.1K)	All Managers (Combined)	$1.8M	2.0% ($1.8M/$90.0M)	QoQ -19.17% (-$421.0K) YoY NEW(+$1.8M)
Edesa Biotech, Inc.(EDSAcusip27966L306)	687.5K	QoQ NEW(+687.5K) YoY NEW(+687.5K)	All Managers (Combined)	$1.7M	1.9% ($1.7M/$90.0M)	QoQ NEW(+$1.7M) YoY NEW(+$1.7M)
Instil Bio, Inc.(TILcusip45783C200)	69.0K	QoQ NEW(+69.0K) YoY NEW(+69.0K)	All Managers (Combined)	$1.2M	1.3% ($1.2M/$90.0M)	QoQ NEW(+$1.2M) YoY NEW(+$1.2M)
Rezolute, Inc.(RZLTcusip76200L309)	400.0K	QoQ -50.00% (-400.0K) YoY 0.00% (+0)	All Managers (Combined)	$1.2M	1.3% ($1.2M/$90.0M)	QoQ -70.40% (-$2.8M) YoY +13.72% (+$140.0K)
Eledon Pharmaceuticals, Inc.(ELDNcusip28617K101)	324.0K	QoQ 0.00% (-0) YoY NEW(+324.0K)	All Managers (Combined)	$1.1M	1.2% ($1.1M/$90.0M)	QoQ -17.71% (-$236.5K) YoY NEW(+$1.1M)
Perspective Therapeutics, Inc.(CATXcusip46489V302)	500.0K	QoQ 0.00% (-0) YoY NEW(+500.0K)	All Managers (Combined)	$1.1M	1.2% ($1.1M/$90.0M)	QoQ -33.22% (-$530.0K) YoY NEW(+$1.1M)
Jasper Therapeutics, Inc.(JSPRcusip471871202)	245.3K	QoQ -79.35% (-943.2K) YoY -13.43% (-38.1K)	All Managers (Combined)	$1.1M	1.2% ($1.1M/$90.0M)	QoQ -95.84% (-$24.4M) YoY -85.35% (-$6.1M)
GERON CORP(GERNcusip374163103)	655.0K	QoQ +1236.73% (+606.0K) YoY +31.00% (-155.0K)	All Managers (Combined)	$1.0M	1.2% ($1.0M/$90.0M)	QoQ +500.39% (+$868.0K) YoY -36.88% (-$608.5K)